Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer treatment-related neuropathic pain syndromes--epidemiology and treatment: an update.

Literature DB >> 25239766

Cancer treatment-related neuropathic pain syndromes--epidemiology and treatment: an update.

Ellen M Lavoie Smith¹, Celia M Bridges, Grace Kanzawa, Robert Knoerl, James P Kelly, Anna Berezovsky, Charis Woo.

Abstract

Cancer treatment-related chronic neuropathic pain (NP) is a pervasive and distressing problem that negatively influences function and quality of life for countless cancer survivors. It occurs because of cancer treatment-induced damage to peripheral and central nervous system structures. NP becomes chronic when pain signal transmission persists, eventually sensitizing neurons in the dorsal horn and other pain-processing regions in the central nervous system. Frequently overlooked, NP due to cancer treatment has been understudied. Consequently, only a few pharmacologic interventions have been shown to be effective based on the results of randomized controlled trials. Future research designed to explore pathophysiologic mechanisms and effective mechanism-targeted interventions is sorely needed.

Entities: Disease

Mesh：

Substances：
Antineoplastic Agents

Year: 2014 PMID： 25239766 DOI： 10.1007/s11916-014-0459-7

Source DB: PubMed Journal: Curr Pain Headache Rep ISSN： 1534-3081

94 in total

Review 1. The evidence for pharmacologic treatment of neuropathic cancer pain: beneficial and adverse effects.

Authors: Joost L M Jongen; Mark L Huijsman; Jairo Jessurun; Kennedy Ogenio; David Schipper; Daan R C Verkouteren; Peter W Moorman; Carin C D van der Rijt; Kris C Vissers
Journal: J Pain Symptom Manage Date: 2013-02-12 Impact factor: 3.612

Review 2. Prevalence of pain in patients with cancer: a systematic review of the past 40 years.

Authors: M H J van den Beuken-van Everdingen; J M de Rijke; A G Kessels; H C Schouten; M van Kleef; J Patijn
Journal: Ann Oncol Date: 2007-03-12 Impact factor: 32.976

Review 3. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.

Authors: Robert H Dworkin; Alec B O'Connor; Joseph Audette; Ralf Baron; Geoffrey K Gourlay; Maija L Haanpää; Joel L Kent; Elliot J Krane; Alyssa A Lebel; Robert M Levy; Sean C Mackey; John Mayer; Christine Miaskowski; Srinivasa N Raja; Andrew S C Rice; Kenneth E Schmader; Brett Stacey; Steven Stanos; Rolf-Detlef Treede; Dennis C Turk; Gary A Walco; Christopher D Wells
Journal: Mayo Clin Proc Date: 2010-03 Impact factor: 7.616

4. Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1.

Authors: Charles L Loprinzi; Brandi N Reeves; Shaker R Dakhil; Jeff A Sloan; Sherry L Wolf; Kelli N Burger; Arif Kamal; Nguyet A Le-Lindqwister; Gamini S Soori; Anthony J Jaslowski; Paul J Novotny; Daniel H Lachance
Journal: J Clin Oncol Date: 2011-03-07 Impact factor: 44.544

Review 5. Phantom limb pain: a review of the literature on attributes and potential mechanisms.

Authors: A Hill
Journal: J Pain Symptom Manage Date: 1999-02 Impact factor: 3.612

6. Differences in depression, posttraumatic stress disorder, and lifetime trauma exposure in formerly abused women with mild versus moderate to severe chronic pain.

Authors: Janice Humphreys; Bruce A Cooper; Christine Miaskowski
Journal: J Interpers Violence Date: 2010-02-02

Review 7. Chemotherapy-induced neuropathy.

Authors: Anthony J Windebank; Wolfgang Grisold
Journal: J Peripher Nerv Syst Date: 2008-03 Impact factor: 3.494

8. Enhanced presurgical pain temporal summation response predicts post-thoracotomy pain intensity during the acute postoperative phase.

Authors: Irit Weissman-Fogel; Yelena Granovsky; Yonathan Crispel; Alon Ben-Nun; Lael Anson Best; David Yarnitsky; Michal Granot
Journal: J Pain Date: 2009-04-23 Impact factor: 5.820

9. Comparison of continuous local anaesthetic and systemic pain treatment after axillary lymphadenectomy in breast carcinoma patients - a prospective randomized study.

Authors: Branka Strazisar; Nikola Besic
Journal: Radiol Oncol Date: 2013-05-21 Impact factor: 2.991

10. Neurological Adverse Effects after Radiation Therapy for Stage II Seminoma.

Authors: Liv Ebbeskov Lauritsen; Peter Meidahl Petersen; Gedske Daugaard
Journal: Case Rep Oncol Date: 2012-08-15

13 in total

Review 1. Podiatric Adverse Events and Foot Care in Cancer Patients and Survivors _{Awareness, Education, and Literature Review}.

Authors: Mario E Lacouture; David J Kopsky; Raphael Lilker; Fiona Damstra; Mecheline H M van der Linden; Azael Freites-Martinez; Mischa P M Nagel
Journal: J Am Podiatr Med Assoc Date: 2018-11

2. Neuropathic Pain in Pediatric Oncology: A Clinical Decision Algorithm.

Authors: Doralina L Anghelescu; Jessica Michala Tesney
Journal: Paediatr Drugs Date: 2019-04 Impact factor: 3.022

3. Electronic versus paper-pencil methods for assessing chemotherapy-induced peripheral neuropathy.

Authors: Robert Knoerl; Evan Gray; Carrie Stricker; Sandra A Mitchell; Kelsey Kippe; Gloria Smith; William N Dudley; Ellen M Lavoie Smith
Journal: Support Care Cancer Date: 2017-06-02 Impact factor: 3.603

4. Characterizing patient-clinician chemotherapy-induced peripheral neuropathy assessment and management communication approaches.

Authors: Robert Knoerl; Ellen M L Smith; Amy Han; Allison Doe; Katelyn Scott; Donna L Berry
Journal: Patient Educ Couns Date: 2019-04-09

5. Risk of incident claims for chemotherapy-induced peripheral neuropathy among women with breast cancer in a Medicare population.

Authors: Mark K Greenwald; Julie J Ruterbusch; Jennifer L Beebe-Dimmer; Michael S Simon; Terrance L Albrecht; Ann G Schwartz
Journal: Cancer Date: 2018-11-02 Impact factor: 6.860

6. Potential mediators of improvement in painful chemotherapy-induced peripheral neuropathy via a web-based cognitive behavioural intervention.

Authors: Robert Knoerl; Debra L Barton; Janean E Holden; John C Krauss; Beth LaVasseur; Ellen M L Smith
Journal: Can Oncol Nurs J Date: 2018-07-01

7. Palliative care with cervical intrathecal infusion and external pump for a late-stage cancer patient with refractory pain: A case report.

Authors: Yanxin Ju; Demin Tian; Yanqin Tan; Zhijian Fu
Journal: Medicine (Baltimore) Date: 2018-01 Impact factor: 1.889

Cancer treatment-related neuropathic pain syndromes--epidemiology and treatment: an update.

Review 1. The evidence for pharmacologic treatment of neuropathic cancer pain: beneficial and adverse effects.

Review 2. Prevalence of pain in patients with cancer: a systematic review of the past 40 years.

Review 3. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.

4. Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1.

Review 5. Phantom limb pain: a review of the literature on attributes and potential mechanisms.

6. Differences in depression, posttraumatic stress disorder, and lifetime trauma exposure in formerly abused women with mild versus moderate to severe chronic pain.

Review 7. Chemotherapy-induced neuropathy.

8. Enhanced presurgical pain temporal summation response predicts post-thoracotomy pain intensity during the acute postoperative phase.

9. Comparison of continuous local anaesthetic and systemic pain treatment after axillary lymphadenectomy in breast carcinoma patients - a prospective randomized study.

10. Neurological Adverse Effects after Radiation Therapy for Stage II Seminoma.

Review 1. Podiatric Adverse Events and Foot Care in Cancer Patients and Survivors _{Awareness, Education, and Literature Review}.

2. Neuropathic Pain in Pediatric Oncology: A Clinical Decision Algorithm.

3. Electronic versus paper-pencil methods for assessing chemotherapy-induced peripheral neuropathy.

4. Characterizing patient-clinician chemotherapy-induced peripheral neuropathy assessment and management communication approaches.

5. Risk of incident claims for chemotherapy-induced peripheral neuropathy among women with breast cancer in a Medicare population.

6. Potential mediators of improvement in painful chemotherapy-induced peripheral neuropathy via a web-based cognitive behavioural intervention.

7. Palliative care with cervical intrathecal infusion and external pump for a late-stage cancer patient with refractory pain: A case report.

8. Effect of Preoperative Oral Amantadine on Acute and Chronic Postoperative Pain After Mandibular Fracture Surgery.

Review 9. A Systematic Review: Mindfulness Intervention for Cancer-Related Pain.

Review 10. Interleukin-6: an emerging regulator of pathological pain.

Review 1. The evidence for pharmacologic treatment of neuropathic cancer pain: beneficial and adverse effects.

Review 2. Prevalence of pain in patients with cancer: a systematic review of the past 40 years.

Review 3. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.

Review 5. Phantom limb pain: a review of the literature on attributes and potential mechanisms.

Review 7. Chemotherapy-induced neuropathy.

Review 1. Podiatric Adverse Events and Foot Care in Cancer Patients and Survivors Awareness, Education, and Literature Review.

Review 9. A Systematic Review: Mindfulness Intervention for Cancer-Related Pain.

Review 10. Interleukin-6: an emerging regulator of pathological pain.

Review 1. Podiatric Adverse Events and Foot Care in Cancer Patients and Survivors _{Awareness, Education, and Literature Review}.